Shopping Cart 0
Cart Subtotal
AED 0

Global Hepatitis A Vaccine Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 12772

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 19157

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 25543
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.

Two types of HAV vaccines are currently available internationally:

1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).

2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.

Scope of the Report:

This report focuses on the Hepatitis A Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.

The classification of Hepatitis A Vaccine includes Inactivated Vaccine, Live Attenuated Vaccine, and the sales proportion of Inactivated Vaccine in 2017 is about 70.8%, and the proportion is increasing trend from 2013 to 2018.

Inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).

The worldwide market for Hepatitis A Vaccine is expected to grow at a CAGR of roughly 2.8% over the next five years, will reach 770 million USD in 2023, from 650 million USD in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

GSK

Merck

Sanofi

Sinovac

Zhejiang Pukang

Changchun Institute of Biological

Kaketsuken

IMBCA

ChangSheng

Convac

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Inactivated Vaccine

Live Attenuated Vaccine

Market Segment by Applications, can be divided into

Government Institution

Private Sector

Other

There are 15 Chapters to deeply display the global Hepatitis A Vaccine market.

Chapter 1, to describe Hepatitis A Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Hepatitis A Vaccine, with sales, revenue, and price of Hepatitis A Vaccine, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Hepatitis A Vaccine, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Hepatitis A Vaccine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Hepatitis A Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

READ MORE

Table Of Content

Scope

Table of Contents

1 Market Overview

1.1 Hepatitis A Vaccine Introduction

1.2 Market Analysis by Type

1.2.1 Inactivated Vaccine

1.2.2 Live Attenuated Vaccine

1.3 Market Analysis by Applications

1.3.1 Government Institution

1.3.2 Private Sector

1.3.3 Other

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 GSK

2.1.1 Business Overview

2.1.2 Hepatitis A Vaccine Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 GSK Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Merck

2.2.1 Business Overview

2.2.2 Hepatitis A Vaccine Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Merck Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Sanofi

2.3.1 Business Overview

2.3.2 Hepatitis A Vaccine Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Sanofi Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Sinovac

2.4.1 Business Overview

2.4.2 Hepatitis A Vaccine Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Sinovac Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Zhejiang Pukang

2.5.1 Business Overview

2.5.2 Hepatitis A Vaccine Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Changchun Institute of Biological

2.6.1 Business Overview

2.6.2 Hepatitis A Vaccine Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Changchun Institute of Biological Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Kaketsuken

2.7.1 Business Overview

2.7.2 Hepatitis A Vaccine Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Kaketsuken Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 IMBCA

2.8.1 Business Overview

2.8.2 Hepatitis A Vaccine Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 IMBCA Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 ChangSheng

2.9.1 Business Overview

2.9.2 Hepatitis A Vaccine Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 ChangSheng Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Convac

2.10.1 Business Overview

2.10.2 Hepatitis A Vaccine Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Convac Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Hepatitis A Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Hepatitis A Vaccine Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Hepatitis A Vaccine Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Hepatitis A Vaccine Manufacturer Market Share in 2017

3.3.2 Top 6 Hepatitis A Vaccine Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Hepatitis A Vaccine Market Analysis by Regions

4.1 Global Hepatitis A Vaccine Sales, Revenue and Market Share by Regions

4.1.1 Global Hepatitis A Vaccine Sales and Market Share by Regions (2013-2018)

4.1.2 Global Hepatitis A Vaccine Revenue and Market Share by Regions (2013-2018)

4.2 North America Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

4.3 Europe Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

4.5 South America Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

5 North America Hepatitis A Vaccine by Countries

5.1 North America Hepatitis A Vaccine Sales, Revenue and Market Share by Countries

5.1.1 North America Hepatitis A Vaccine Sales and Market Share by Countries (2013-2018)

5.1.2 North America Hepatitis A Vaccine Revenue and Market Share by Countries (2013-2018)

5.2 United States Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

5.3 Canada Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

5.4 Mexico Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

6 Europe Hepatitis A Vaccine by Countries

6.1 Europe Hepatitis A Vaccine Sales, Revenue and Market Share by Countries

6.1.1 Europe Hepatitis A Vaccine Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Hepatitis A Vaccine Revenue and Market Share by Countries (2013-2018)

6.2 Germany Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

6.3 UK Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

6.4 France Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

6.5 Russia Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

6.6 Italy Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

7 Asia-Pacific Hepatitis A Vaccine by Countries

7.1 Asia-Pacific Hepatitis A Vaccine Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Hepatitis A Vaccine Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Hepatitis A Vaccine Revenue and Market Share by Countries (2013-2018)

7.2 China Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

7.3 Japan Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

7.4 Korea Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

7.5 India Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

8 South America Hepatitis A Vaccine by Countries

8.1 South America Hepatitis A Vaccine Sales, Revenue and Market Share by Countries

8.1.1 South America Hepatitis A Vaccine Sales and Market Share by Countries (2013-2018)

8.1.2 South America Hepatitis A Vaccine Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

8.3 Argentina Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

8.4 Colombia Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

9 Middle East and Africa Hepatitis A Vaccine by Countries

9.1 Middle East and Africa Hepatitis A Vaccine Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Hepatitis A Vaccine Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Hepatitis A Vaccine Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

9.3 UAE Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

9.4 Egypt Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

9.5 Nigeria Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

9.6 South Africa Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

10 Global Hepatitis A Vaccine Market Segment by Type

10.1 Global Hepatitis A Vaccine Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Hepatitis A Vaccine Sales and Market Share by Type (2013-2018)

10.1.2 Global Hepatitis A Vaccine Revenue and Market Share by Type (2013-2018)

10.2 Inactivated Vaccine Sales Growth and Price

10.2.1 Global Inactivated Vaccine Sales Growth (2013-2018)

10.2.2 Global Inactivated Vaccine Price (2013-2018)

10.3 Live Attenuated Vaccine Sales Growth and Price

10.3.1 Global Live Attenuated Vaccine Sales Growth (2013-2018)

10.3.2 Global Live Attenuated Vaccine Price (2013-2018)

11 Global Hepatitis A Vaccine Market Segment by Application

11.1 Global Hepatitis A Vaccine Sales Market Share by Application (2013-2018)

11.2 Government Institution Sales Growth (2013-2018)

11.3 Private Sector Sales Growth (2013-2018)

11.4 Other Sales Growth (2013-2018)

12 Hepatitis A Vaccine Market Forecast (2018-2023)

12.1 Global Hepatitis A Vaccine Sales, Revenue and Growth Rate (2018-2023)

12.2 Hepatitis A Vaccine Market Forecast by Regions (2018-2023)

12.2.1 North America Hepatitis A Vaccine Market Forecast (2018-2023)

12.2.2 Europe Hepatitis A Vaccine Market Forecast (2018-2023)

12.2.3 Asia-Pacific Hepatitis A Vaccine Market Forecast (2018-2023)

12.2.4 South America Hepatitis A Vaccine Market Forecast (2018-2023)

12.2.5 Middle East and Africa Hepatitis A Vaccine Market Forecast (2018-2023)

12.3 Hepatitis A Vaccine Market Forecast by Type (2018-2023)

12.3.1 Global Hepatitis A Vaccine Sales Forecast by Type (2018-2023)

12.3.2 Global Hepatitis A Vaccine Market Share Forecast by Type (2018-2023)

12.4 Hepatitis A Vaccine Market Forecast by Application (2018-2023)

12.4.1 Global Hepatitis A Vaccine Sales Forecast by Application (2018-2023)

12.4.2 Global Hepatitis A Vaccine Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


List Of Table

List of Tables and Figures

Figure Hepatitis A Vaccine Picture

Table Product Specifications of Hepatitis A Vaccine

Figure Global Sales Market Share of Hepatitis A Vaccine by Types in 2017

Table Hepatitis A Vaccine Types for Major Manufacturers

Figure Inactivated Vaccine Picture

Figure Live Attenuated Vaccine Picture

Figure Hepatitis A Vaccine Sales Market Share by Applications in 2017

Figure Government Institution Picture

Figure Private Sector Picture

Figure Other Picture

Figure United States Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure France Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure UK Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure China Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure India Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)

Table GSK Basic Information, Manufacturing Base and Competitors

Table GSK Hepatitis A Vaccine Type and Applications

Table GSK Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Merck Basic Information, Manufacturing Base and Competitors

Table Merck Hepatitis A Vaccine Type and Applications

Table Merck Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Sanofi Basic Information, Manufacturing Base and Competitors

Table Sanofi Hepatitis A Vaccine Type and Applications

Table Sanofi Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Sinovac Basic Information, Manufacturing Base and Competitors

Table Sinovac Hepatitis A Vaccine Type and Applications

Table Sinovac Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Zhejiang Pukang Basic Information, Manufacturing Base and Competitors

Table Zhejiang Pukang Hepatitis A Vaccine Type and Applications

Table Zhejiang Pukang Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Changchun Institute of Biological Basic Information, Manufacturing Base and Competitors

Table Changchun Institute of Biological Hepatitis A Vaccine Type and Applications

Table Changchun Institute of Biological Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Kaketsuken Basic Information, Manufacturing Base and Competitors

Table Kaketsuken Hepatitis A Vaccine Type and Applications

Table Kaketsuken Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table IMBCA Basic Information, Manufacturing Base and Competitors

Table IMBCA Hepatitis A Vaccine Type and Applications

Table IMBCA Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table ChangSheng Basic Information, Manufacturing Base and Competitors

Table ChangSheng Hepatitis A Vaccine Type and Applications

Table ChangSheng Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Convac Basic Information, Manufacturing Base and Competitors

Table Convac Hepatitis A Vaccine Type and Applications

Table Convac Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Hepatitis A Vaccine Sales by Manufacturer (2016-2017)

Figure Global Hepatitis A Vaccine Sales Market Share by Manufacturer in 2016

Figure Global Hepatitis A Vaccine Sales Market Share by Manufacturer in 2017

Table Global Hepatitis A Vaccine Revenue by Manufacturer (2016-2017)

Figure Global Hepatitis A Vaccine Revenue Market Share by Manufacturer in 2016

Figure Global Hepatitis A Vaccine Revenue Market Share by Manufacturer in 2017

Figure Top 3 Hepatitis A Vaccine Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Hepatitis A Vaccine Manufacturer (Revenue) Market Share in 2017

Figure Global Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure Global Hepatitis A Vaccine Revenue and Growth Rate (2013-2018)

Table Global Hepatitis A Vaccine Sales by Regions (2013-2018)

Table Global Hepatitis A Vaccine Sales Market Share by Regions (2013-2018)

Table Global Hepatitis A Vaccine Revenue by Regions (2013-2018)

Figure Global Hepatitis A Vaccine Revenue Market Share by Regions in 2013

Figure Global Hepatitis A Vaccine Revenue Market Share by Regions in 2017

Figure North America Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure Europe Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure South America Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure North America Hepatitis A Vaccine Revenue and Growth Rate (2013-2018)

Table North America Hepatitis A Vaccine Sales by Countries (2013-2018)

Table North America Hepatitis A Vaccine Sales Market Share by Countries (2013-2018)

Figure North America Hepatitis A Vaccine Sales Market Share by Countries in 2013

Figure North America Hepatitis A Vaccine Sales Market Share by Countries in 2017

Table North America Hepatitis A Vaccine Revenue by Countries (2013-2018)

Table North America Hepatitis A Vaccine Revenue Market Share by Countries (2013-2018)

Figure North America Hepatitis A Vaccine Revenue Market Share by Countries in 2013

Figure North America Hepatitis A Vaccine Revenue Market Share by Countries in 2017

Figure United States Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure Canada Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure Mexico Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure Europe Hepatitis A Vaccine Revenue and Growth Rate (2013-2018)

Table Europe Hepatitis A Vaccine Sales by Countries (2013-2018)

Table Europe Hepatitis A Vaccine Sales Market Share by Countries (2013-2018)

Table Europe Hepatitis A Vaccine Revenue by Countries (2013-2018)

Figure Europe Hepatitis A Vaccine Revenue Market Share by Countries in 2016

Figure Europe Hepatitis A Vaccine Revenue Market Share by Countries in 2017

Figure Germany Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure UK Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure France Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure Russia Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure Italy Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Hepatitis A Vaccine Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Hepatitis A Vaccine Sales by Countries (2013-2018)

Table Asia-Pacific Hepatitis A Vaccine Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Hepatitis A Vaccine Sales Market Share by Countries 2017

Table Asia-Pacific Hepatitis A Vaccine Revenue by Countries (2013-2018)

Figure Asia-Pacific Hepatitis A Vaccine Revenue Market Share by Countries 2017

Figure China Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure Japan Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure Korea Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure India Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure Southeast Asia Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure South America Hepatitis A Vaccine Revenue and Growth Rate (2013-2018)

Table South America Hepatitis A Vaccine Sales by Countries (2013-2018)

Table South America Hepatitis A Vaccine Sales Market Share by Countries (2013-2018)

Figure South America Hepatitis A Vaccine Sales Market Share by Countries in 2017

Table South America Hepatitis A Vaccine Revenue by Countries (2013-2018)

Table South America Hepatitis A Vaccine Revenue Market Share by Countries (2013-2018)

Figure South America Hepatitis A Vaccine Revenue Market Share by Countries in 2017

Figure Brazil Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure Argentina Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure Colombia Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Hepatitis A Vaccine Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Hepatitis A Vaccine Sales by Countries (2013-2018)

Table Middle East and Africa Hepatitis A Vaccine Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Hepatitis A Vaccine Sales Market Share by Countries in 2017

Table Middle East and Africa Hepatitis A Vaccine Revenue by Countries (2013-2018)

Table Middle East and Africa Hepatitis A Vaccine Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Hepatitis A Vaccine Revenue Market Share by Countries in 2013

Figure Middle East and Africa Hepatitis A Vaccine Revenue Market Share by Countries in 2017

Figure Saudi Arabia Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure UAE Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure Egypt Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure Nigeria Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure South Africa Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Table Global Hepatitis A Vaccine Sales by Type (2013-2018)

Table Global Hepatitis A Vaccine Sales Share by Type (2013-2018)

Table Global Hepatitis A Vaccine Revenue by Type (2013-2018)

Table Global Hepatitis A Vaccine Revenue Share by Type (2013-2018)

Figure Global Inactivated Vaccine Sales Growth (2013-2018)

Figure Global Inactivated Vaccine Price (2013-2018)

Figure Global Live Attenuated Vaccine Sales Growth (2013-2018)

Figure Global Live Attenuated Vaccine Price (2013-2018)

Table Global Hepatitis A Vaccine Sales by Application (2013-2018)

Table Global Hepatitis A Vaccine Sales Share by Application (2013-2018)

Figure Global Private Sector Sales Growth (2013-2018)

Figure Global Other Sales Growth (2013-2018)

Figure Global Hepatitis A Vaccine Sales, Revenue and Growth Rate (2018-2023)

Table Global Hepatitis A Vaccine Sales Forecast by Regions (2018-2023)

Table Global Hepatitis A Vaccine Market Share Forecast by Regions (2018-2023)

Figure North America Sales Hepatitis A Vaccine Market Forecast (2018-2023)

Figure Europe Sales Hepatitis A Vaccine Market Forecast (2018-2023)

Figure Asia-Pacific Sales Hepatitis A Vaccine Market Forecast (2018-2023)

Figure South America Sales Hepatitis A Vaccine Market Forecast (2018-2023)

Figure Middle East and Africa Sales Hepatitis A Vaccine Market Forecast (2018-2023)

Table Global Hepatitis A Vaccine Sales Forecast by Type (2018-2023)

Table Global Hepatitis A Vaccine Market Share Forecast by Type (2018-2023)

Table Global Hepatitis A Vaccine Sales Forecast by Application (2018-2023)

Table Global Hepatitis A Vaccine Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List

Licence Rights

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

GSK

Merck

Sanofi

Sinovac

Zhejiang Pukang

Changchun Institute of Biological

Kaketsuken

IMBCA

ChangSheng

Convac

Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.

Two types of HAV vaccines are currently available internationally:

1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).

2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.

Scope of the Report:

This report focuses on the Hepatitis A Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.

The classification of Hepatitis A Vaccine includes Inactivated Vaccine, Live Attenuated Vaccine, and the sales proportion of Inactivated Vaccine in 2017 is about 70.8%, and the proportion is increasing trend from 2013 to 2018.

Inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).

The worldwide market for Hepatitis A Vaccine is expected to grow at a CAGR of roughly 2.8% over the next five years, will reach 770 million USD in 2023, from 650 million USD in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

GSK

Merck

Sanofi

Sinovac

Zhejiang Pukang

Changchun Institute of Biological

Kaketsuken

IMBCA

ChangSheng

Convac

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Inactivated Vaccine

Live Attenuated Vaccine

Market Segment by Applications, can be divided into

Government Institution

Private Sector

Other

There are 15 Chapters to deeply display the global Hepatitis A Vaccine market.

Chapter 1, to describe Hepatitis A Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Hepatitis A Vaccine, with sales, revenue, and price of Hepatitis A Vaccine, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Hepatitis A Vaccine, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Hepatitis A Vaccine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Hepatitis A Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

READ MORE

Scope

Table of Contents

1 Market Overview

1.1 Hepatitis A Vaccine Introduction

1.2 Market Analysis by Type

1.2.1 Inactivated Vaccine

1.2.2 Live Attenuated Vaccine

1.3 Market Analysis by Applications

1.3.1 Government Institution

1.3.2 Private Sector

1.3.3 Other

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 GSK

2.1.1 Business Overview

2.1.2 Hepatitis A Vaccine Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 GSK Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Merck

2.2.1 Business Overview

2.2.2 Hepatitis A Vaccine Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Merck Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Sanofi

2.3.1 Business Overview

2.3.2 Hepatitis A Vaccine Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Sanofi Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Sinovac

2.4.1 Business Overview

2.4.2 Hepatitis A Vaccine Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Sinovac Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Zhejiang Pukang

2.5.1 Business Overview

2.5.2 Hepatitis A Vaccine Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Changchun Institute of Biological

2.6.1 Business Overview

2.6.2 Hepatitis A Vaccine Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Changchun Institute of Biological Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Kaketsuken

2.7.1 Business Overview

2.7.2 Hepatitis A Vaccine Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Kaketsuken Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 IMBCA

2.8.1 Business Overview

2.8.2 Hepatitis A Vaccine Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 IMBCA Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 ChangSheng

2.9.1 Business Overview

2.9.2 Hepatitis A Vaccine Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 ChangSheng Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Convac

2.10.1 Business Overview

2.10.2 Hepatitis A Vaccine Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Convac Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Hepatitis A Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Hepatitis A Vaccine Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Hepatitis A Vaccine Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Hepatitis A Vaccine Manufacturer Market Share in 2017

3.3.2 Top 6 Hepatitis A Vaccine Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Hepatitis A Vaccine Market Analysis by Regions

4.1 Global Hepatitis A Vaccine Sales, Revenue and Market Share by Regions

4.1.1 Global Hepatitis A Vaccine Sales and Market Share by Regions (2013-2018)

4.1.2 Global Hepatitis A Vaccine Revenue and Market Share by Regions (2013-2018)

4.2 North America Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

4.3 Europe Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

4.5 South America Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

5 North America Hepatitis A Vaccine by Countries

5.1 North America Hepatitis A Vaccine Sales, Revenue and Market Share by Countries

5.1.1 North America Hepatitis A Vaccine Sales and Market Share by Countries (2013-2018)

5.1.2 North America Hepatitis A Vaccine Revenue and Market Share by Countries (2013-2018)

5.2 United States Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

5.3 Canada Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

5.4 Mexico Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

6 Europe Hepatitis A Vaccine by Countries

6.1 Europe Hepatitis A Vaccine Sales, Revenue and Market Share by Countries

6.1.1 Europe Hepatitis A Vaccine Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Hepatitis A Vaccine Revenue and Market Share by Countries (2013-2018)

6.2 Germany Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

6.3 UK Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

6.4 France Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

6.5 Russia Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

6.6 Italy Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

7 Asia-Pacific Hepatitis A Vaccine by Countries

7.1 Asia-Pacific Hepatitis A Vaccine Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Hepatitis A Vaccine Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Hepatitis A Vaccine Revenue and Market Share by Countries (2013-2018)

7.2 China Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

7.3 Japan Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

7.4 Korea Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

7.5 India Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

8 South America Hepatitis A Vaccine by Countries

8.1 South America Hepatitis A Vaccine Sales, Revenue and Market Share by Countries

8.1.1 South America Hepatitis A Vaccine Sales and Market Share by Countries (2013-2018)

8.1.2 South America Hepatitis A Vaccine Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

8.3 Argentina Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

8.4 Colombia Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

9 Middle East and Africa Hepatitis A Vaccine by Countries

9.1 Middle East and Africa Hepatitis A Vaccine Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Hepatitis A Vaccine Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Hepatitis A Vaccine Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

9.3 UAE Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

9.4 Egypt Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

9.5 Nigeria Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

9.6 South Africa Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

10 Global Hepatitis A Vaccine Market Segment by Type

10.1 Global Hepatitis A Vaccine Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Hepatitis A Vaccine Sales and Market Share by Type (2013-2018)

10.1.2 Global Hepatitis A Vaccine Revenue and Market Share by Type (2013-2018)

10.2 Inactivated Vaccine Sales Growth and Price

10.2.1 Global Inactivated Vaccine Sales Growth (2013-2018)

10.2.2 Global Inactivated Vaccine Price (2013-2018)

10.3 Live Attenuated Vaccine Sales Growth and Price

10.3.1 Global Live Attenuated Vaccine Sales Growth (2013-2018)

10.3.2 Global Live Attenuated Vaccine Price (2013-2018)

11 Global Hepatitis A Vaccine Market Segment by Application

11.1 Global Hepatitis A Vaccine Sales Market Share by Application (2013-2018)

11.2 Government Institution Sales Growth (2013-2018)

11.3 Private Sector Sales Growth (2013-2018)

11.4 Other Sales Growth (2013-2018)

12 Hepatitis A Vaccine Market Forecast (2018-2023)

12.1 Global Hepatitis A Vaccine Sales, Revenue and Growth Rate (2018-2023)

12.2 Hepatitis A Vaccine Market Forecast by Regions (2018-2023)

12.2.1 North America Hepatitis A Vaccine Market Forecast (2018-2023)

12.2.2 Europe Hepatitis A Vaccine Market Forecast (2018-2023)

12.2.3 Asia-Pacific Hepatitis A Vaccine Market Forecast (2018-2023)

12.2.4 South America Hepatitis A Vaccine Market Forecast (2018-2023)

12.2.5 Middle East and Africa Hepatitis A Vaccine Market Forecast (2018-2023)

12.3 Hepatitis A Vaccine Market Forecast by Type (2018-2023)

12.3.1 Global Hepatitis A Vaccine Sales Forecast by Type (2018-2023)

12.3.2 Global Hepatitis A Vaccine Market Share Forecast by Type (2018-2023)

12.4 Hepatitis A Vaccine Market Forecast by Application (2018-2023)

12.4.1 Global Hepatitis A Vaccine Sales Forecast by Application (2018-2023)

12.4.2 Global Hepatitis A Vaccine Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


List Of Table

List of Tables and Figures

Figure Hepatitis A Vaccine Picture

Table Product Specifications of Hepatitis A Vaccine

Figure Global Sales Market Share of Hepatitis A Vaccine by Types in 2017

Table Hepatitis A Vaccine Types for Major Manufacturers

Figure Inactivated Vaccine Picture

Figure Live Attenuated Vaccine Picture

Figure Hepatitis A Vaccine Sales Market Share by Applications in 2017

Figure Government Institution Picture

Figure Private Sector Picture

Figure Other Picture

Figure United States Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure France Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure UK Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure China Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure India Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)

Table GSK Basic Information, Manufacturing Base and Competitors

Table GSK Hepatitis A Vaccine Type and Applications

Table GSK Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Merck Basic Information, Manufacturing Base and Competitors

Table Merck Hepatitis A Vaccine Type and Applications

Table Merck Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Sanofi Basic Information, Manufacturing Base and Competitors

Table Sanofi Hepatitis A Vaccine Type and Applications

Table Sanofi Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Sinovac Basic Information, Manufacturing Base and Competitors

Table Sinovac Hepatitis A Vaccine Type and Applications

Table Sinovac Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Zhejiang Pukang Basic Information, Manufacturing Base and Competitors

Table Zhejiang Pukang Hepatitis A Vaccine Type and Applications

Table Zhejiang Pukang Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Changchun Institute of Biological Basic Information, Manufacturing Base and Competitors

Table Changchun Institute of Biological Hepatitis A Vaccine Type and Applications

Table Changchun Institute of Biological Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Kaketsuken Basic Information, Manufacturing Base and Competitors

Table Kaketsuken Hepatitis A Vaccine Type and Applications

Table Kaketsuken Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table IMBCA Basic Information, Manufacturing Base and Competitors

Table IMBCA Hepatitis A Vaccine Type and Applications

Table IMBCA Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table ChangSheng Basic Information, Manufacturing Base and Competitors

Table ChangSheng Hepatitis A Vaccine Type and Applications

Table ChangSheng Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Convac Basic Information, Manufacturing Base and Competitors

Table Convac Hepatitis A Vaccine Type and Applications

Table Convac Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Hepatitis A Vaccine Sales by Manufacturer (2016-2017)

Figure Global Hepatitis A Vaccine Sales Market Share by Manufacturer in 2016

Figure Global Hepatitis A Vaccine Sales Market Share by Manufacturer in 2017

Table Global Hepatitis A Vaccine Revenue by Manufacturer (2016-2017)

Figure Global Hepatitis A Vaccine Revenue Market Share by Manufacturer in 2016

Figure Global Hepatitis A Vaccine Revenue Market Share by Manufacturer in 2017

Figure Top 3 Hepatitis A Vaccine Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Hepatitis A Vaccine Manufacturer (Revenue) Market Share in 2017

Figure Global Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure Global Hepatitis A Vaccine Revenue and Growth Rate (2013-2018)

Table Global Hepatitis A Vaccine Sales by Regions (2013-2018)

Table Global Hepatitis A Vaccine Sales Market Share by Regions (2013-2018)

Table Global Hepatitis A Vaccine Revenue by Regions (2013-2018)

Figure Global Hepatitis A Vaccine Revenue Market Share by Regions in 2013

Figure Global Hepatitis A Vaccine Revenue Market Share by Regions in 2017

Figure North America Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure Europe Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure South America Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure North America Hepatitis A Vaccine Revenue and Growth Rate (2013-2018)

Table North America Hepatitis A Vaccine Sales by Countries (2013-2018)

Table North America Hepatitis A Vaccine Sales Market Share by Countries (2013-2018)

Figure North America Hepatitis A Vaccine Sales Market Share by Countries in 2013

Figure North America Hepatitis A Vaccine Sales Market Share by Countries in 2017

Table North America Hepatitis A Vaccine Revenue by Countries (2013-2018)

Table North America Hepatitis A Vaccine Revenue Market Share by Countries (2013-2018)

Figure North America Hepatitis A Vaccine Revenue Market Share by Countries in 2013

Figure North America Hepatitis A Vaccine Revenue Market Share by Countries in 2017

Figure United States Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure Canada Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure Mexico Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure Europe Hepatitis A Vaccine Revenue and Growth Rate (2013-2018)

Table Europe Hepatitis A Vaccine Sales by Countries (2013-2018)

Table Europe Hepatitis A Vaccine Sales Market Share by Countries (2013-2018)

Table Europe Hepatitis A Vaccine Revenue by Countries (2013-2018)

Figure Europe Hepatitis A Vaccine Revenue Market Share by Countries in 2016

Figure Europe Hepatitis A Vaccine Revenue Market Share by Countries in 2017

Figure Germany Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure UK Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure France Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure Russia Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure Italy Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Hepatitis A Vaccine Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Hepatitis A Vaccine Sales by Countries (2013-2018)

Table Asia-Pacific Hepatitis A Vaccine Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Hepatitis A Vaccine Sales Market Share by Countries 2017

Table Asia-Pacific Hepatitis A Vaccine Revenue by Countries (2013-2018)

Figure Asia-Pacific Hepatitis A Vaccine Revenue Market Share by Countries 2017

Figure China Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure Japan Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure Korea Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure India Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure Southeast Asia Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure South America Hepatitis A Vaccine Revenue and Growth Rate (2013-2018)

Table South America Hepatitis A Vaccine Sales by Countries (2013-2018)

Table South America Hepatitis A Vaccine Sales Market Share by Countries (2013-2018)

Figure South America Hepatitis A Vaccine Sales Market Share by Countries in 2017

Table South America Hepatitis A Vaccine Revenue by Countries (2013-2018)

Table South America Hepatitis A Vaccine Revenue Market Share by Countries (2013-2018)

Figure South America Hepatitis A Vaccine Revenue Market Share by Countries in 2017

Figure Brazil Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure Argentina Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure Colombia Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Hepatitis A Vaccine Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Hepatitis A Vaccine Sales by Countries (2013-2018)

Table Middle East and Africa Hepatitis A Vaccine Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Hepatitis A Vaccine Sales Market Share by Countries in 2017

Table Middle East and Africa Hepatitis A Vaccine Revenue by Countries (2013-2018)

Table Middle East and Africa Hepatitis A Vaccine Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Hepatitis A Vaccine Revenue Market Share by Countries in 2013

Figure Middle East and Africa Hepatitis A Vaccine Revenue Market Share by Countries in 2017

Figure Saudi Arabia Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure UAE Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure Egypt Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure Nigeria Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Figure South Africa Hepatitis A Vaccine Sales and Growth Rate (2013-2018)

Table Global Hepatitis A Vaccine Sales by Type (2013-2018)

Table Global Hepatitis A Vaccine Sales Share by Type (2013-2018)

Table Global Hepatitis A Vaccine Revenue by Type (2013-2018)

Table Global Hepatitis A Vaccine Revenue Share by Type (2013-2018)

Figure Global Inactivated Vaccine Sales Growth (2013-2018)

Figure Global Inactivated Vaccine Price (2013-2018)

Figure Global Live Attenuated Vaccine Sales Growth (2013-2018)

Figure Global Live Attenuated Vaccine Price (2013-2018)

Table Global Hepatitis A Vaccine Sales by Application (2013-2018)

Table Global Hepatitis A Vaccine Sales Share by Application (2013-2018)

Figure Global Private Sector Sales Growth (2013-2018)

Figure Global Other Sales Growth (2013-2018)

Figure Global Hepatitis A Vaccine Sales, Revenue and Growth Rate (2018-2023)

Table Global Hepatitis A Vaccine Sales Forecast by Regions (2018-2023)

Table Global Hepatitis A Vaccine Market Share Forecast by Regions (2018-2023)

Figure North America Sales Hepatitis A Vaccine Market Forecast (2018-2023)

Figure Europe Sales Hepatitis A Vaccine Market Forecast (2018-2023)

Figure Asia-Pacific Sales Hepatitis A Vaccine Market Forecast (2018-2023)

Figure South America Sales Hepatitis A Vaccine Market Forecast (2018-2023)

Figure Middle East and Africa Sales Hepatitis A Vaccine Market Forecast (2018-2023)

Table Global Hepatitis A Vaccine Sales Forecast by Type (2018-2023)

Table Global Hepatitis A Vaccine Market Share Forecast by Type (2018-2023)

Table Global Hepatitis A Vaccine Sales Forecast by Application (2018-2023)

Table Global Hepatitis A Vaccine Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

GSK

Merck

Sanofi

Sinovac

Zhejiang Pukang

Changchun Institute of Biological

Kaketsuken

IMBCA

ChangSheng

Convac

chat_bubbleLet's Chat